Overivew

NSABP B-52*

Objective

Docetaxel, carboplatin, trastuzumab and pertuzumab with or without estrogen deprivation in treating patients with hormone receptor-positive, HER2-positive operable or locally advanced breast cancer.

Clinical Trial Categories

Oncology

Sponsor(s)

National Cancer Institute (NCI)

Contact

Research study staff: 425.688.5407

Complete the online contact information form

Location

Overlake Medical Center
1035 116th Ave. NE 
Bellevue, WA 98004
Main: 425.688.5000

*Please note: This trial is no longer recruiting new patients.
View all hospital services

View all hospital services

Make a gift

Make a gift

Need urgent care?

Need urgent care?